中文 English Pусский العربية

Dr. Changsong Qi: In 2025, China’s CAR-T Cell Therapy Leads the World — Breaking Through Solid Tumors Like Gastric and Pancreatic Cancer

2025-4-17
View
Dr. Jing Pan: Autologous CD7 CAR-T cells Generated without T cell Pre-selection to Broaden Access for R/R T-ALL Patients

2025-4-15
View
Professor Ming Lu: Emerging Therapies in the Field of Neuroendocrine Neoplasms (NENs)

2025-4-15
View
Dr. Jianyun Liao: Redefining Treatment Paradigms to Tackle Post-Transplant Immune Hemolytic Disease

2025-4-15
View
Professor Jin Li: Interpreting the New Findings of CheckMate-8HW — Entering the Era of Dual Immunotherapy for Advanced MSI-H/dMMR Colorectal Cancer

2025-4-15
View
Professor Chunfu Li: In-depth Interpretation of TCRαβ+ T Cell-Depleted Hematopoietic Stem Cell Transplantation

2025-4-15
View

Hematologic Disease

Solid Tumor

Specialized Services

International Patient Guide

Follow Us

Email: international.service@gobroadhealthcare.com

WhatsAPP: +86 15901185120

Address: 12th Floor, Lize SOHO South Tower, No. 20 Lize Road, Lize Financial Business District, Fengtai District, Beijing,China

Beijing GoBroad Medical Technology Group Co. Ltd. Beijing ICP No.19005517-3 Beijing Public Network Security No. 11010502037763

Contact Information

Email: international.service@gobroadhealthcare.com

WhatsAPP: +86 15901185120

Address: 12th Floor, Lize SOHO South Tower, No. 20 Lize Road, Lize Financial Business District, Fengtai District, Beijing,China

Follow Us

Beijing GoBroad Medical Technology Group Co. Ltd. Beijing ICP No.19005517-3 Beijing Public Network Security No. 11010502037763

Remote Second Opinion